跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Lisnoxl-10 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Lisnoxl-10
Approved
STANDARD
Lisnoxl-10
XL Laboratories Pvt. Ltd
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
2c11a6709d969d9c
Company
XL Laboratories Pvt. Ltd
Type
Standard
Approval Details
Approval Id
2c11a6709d969d9c
Drug Approval Philippines Name
Lisnoxl-10
Product Name
Lisnoxl-10
Registration Number
DRP-12130
Brand Name
Lisnoxl-10
Generic Name
Lisinopril
Dosage Form
Tablet
Dosage Strength
10 mg
Manufacturer
XL Laboratories Pvt. Ltd
Importer
Ambica International Corporation
Distributor
Ambica International Corporation
Issuance Date
25 July 2024
Expiry Date
06 January 2030
Pharmacologic Category
Angiotensin-Converting Enzyme (ACE) Inhibitor
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
2c11a6709d969d9c
Type
Standard
Back to Philippines FDA Approvals